As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive ...

Wellness company Medifast (NYSE:MED) will be reporting results tomorrow after market hours. Here’s what investors should know ...

Wellness company Medifast (NYSE:MED) reported Q3 CY2024 results exceeding the market’s revenue expectations, but sales fell 40.6% year on year to $140.2 million. On the other hand, next quarter’s ...

Medifast, Inc. MED is likely to register a decrease ... Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is among the most innovative ...

Medifast assumes no obligation to update any ... it excludes any gains or losses from changes in the market price of our LifeMD common stock holdings, which we are unable to estimate.

DA Davidson analyst Linda Bolton Weiser upgraded Medifast (MED) to Neutral from Underperform with a price target of $17, up from $16.50. With ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Medifast Inc. (MED) on Monday reported profit of $1.1 million in its third quarter. On a per-share basis, the Baltimore-based company said it had profit of 10 cents.